What are the causes of total bilirubin elevation?

Causes of Total Bilirubin Elevation

Total bilirubin elevation results from either unconjugated hyperbilirubinemia (due to hemolysis or impaired conjugation) or conjugated hyperbilirubinemia (due to parenchymal liver disease or biliary obstruction), with the critical first step being fractionation to determine which type is present. 1

Pathophysiologic Framework

Bilirubin exists in two forms that determine the differential diagnosis 1:

• Unconjugated (indirect) bilirubin: Insoluble form transported to the liver for conjugation
• Conjugated (direct) bilirubin: Soluble form ready for biliary excretion

Causes by Bilirubin Type

Unconjugated Hyperbilirubinemia

Primary causes include:

• Gilbert's syndrome: The most common cause of isolated elevated bilirubin, resulting from reduced glucuronyltransferase activity 1

  • In the absence of hemolysis, if the majority of elevated bilirubin is unconjugated, the cause is virtually always Gilbert's syndrome 1
  • These patients should be fully reassured as this condition is benign 1
  • SLCO1B1 gene polymorphisms (particularly *15 allele carriers) are associated with higher baseline bilirubin levels 2

• Hemolysis: Excessive breakdown of red blood cells producing bilirubin faster than the liver can conjugate it 1, 3

• Impaired hepatic uptake: Defects in bilirubin transport into hepatocytes 3

• Medication-induced: Certain drugs can interfere with conjugation 1, 4

  • Rifampicin increases unconjugated, conjugated, and total bilirubin levels 2
  • Naproxen overdose can cause spurious laboratory elevation due to metabolite (O-desmethylnaproxen) interference with bilirubin assays 4

Conjugated Hyperbilirubinemia

Primary causes include:

• Parenchymal liver disease: Any hepatocellular injury reducing functional hepatocyte mass 1, 3

  • Hepatitis (viral, autoimmune, drug-induced)
  • Cirrhosis
  • Acute liver failure

• Biliary obstruction: Inability of bile to reach the small bowel 1, 3

  • Common bile duct stones (higher initial bilirubin levels predict presence: mean 3.74 vs 2.29 mg/dL) 5
  • Strictures
  • Malignancy
  • Cholestasis

• Defects in bile clearance proteins: Impaired transport mechanisms for conjugated bilirubin excretion 3

Diagnostic Algorithm

When evaluating hyperbilirubinemia, follow this sequence:

1. Fractionate the bilirubin to determine conjugated vs. unconjugated predominance 1

2. For unconjugated hyperbilirubinemia:

   • Evaluate for hemolysis (CBC, reticulocyte count, haptoglobin, LDH) 1
   • Review medications for potential interference 1, 4
   • If isolated and mild in asymptomatic adults, consider Gilbert's syndrome 1

3. For conjugated hyperbilirubinemia:

   • Assess alkaline phosphatase levels to distinguish hepatocellular vs. cholestatic patterns 1
   • If alkaline phosphatase is elevated, exclude biliary obstruction with imaging 1
   • Obtain hepatitis serologies and assess for other causes of liver disease 1

Critical Clinical Pitfalls

Avoid these common errors:

• Laboratory interference: Naproxen metabolites can cause falsely elevated total bilirubin on certain assays without true hyperbilirubinemia 4

  • When clinical presentation doesn't match laboratory findings, consider assay interference

• Drug-induced elevations: Elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients with Gilbert's syndrome causes isolated bilirubin elevation without liver injury 6

  • Genetic testing for Gilbert's syndrome prevents unnecessary drug discontinuation 6

• Neonatal considerations: In neonates with conjugated bilirubin >25 μmol/L, urgent pediatric referral is essential for possible liver disease 1

• Timing of evaluation: For patients with cholecystitis and elevated bilirubin, immediate imaging is superior to serial bilirubin monitoring for detecting common bile duct stones 5

The evaluation must always be interpreted in the complete clinical context, including detailed medication history (prescription, over-the-counter, herbs, vitamins), alcohol consumption, risk factors for liver disease, and physical examination findings. 1